$12.64
-0.39-2.99%
At close: -
$12.31
-0.33-2.61%
After Hours: Jan 2, 8:05 AM EDT
Comments
Loading...
Number of Stock Holdings
86
Number of Bond Holdings
-
Total Holdings
87
Number of ETFs
-
Range Cancer Therapeutics ETF (NASDAQ:CNCR), Top Holdings
Range Cancer Therapeutics ETF (NASDAQ: CNCR)
| Ticker | Name | Share % | |
|---|---|---|---|
| JANX | Janux Therapeutics Inc. | 4.17% | |
| MGNX | Macrogenics Inc | 3.27% | |
| MRSN | Mersana Therapeutics Inc | 3.26% | |
| YMAB | Y-Mabs Therapeutics Inc Com | 2.85% | |
| FATE | Fate Therapeutics Inc | 2.74% | |
| IOVA | Iovance Biotherapeutics Inc | 2.57% | |
| AMAM | Ambrx Inc | 2.54% | |
| IBRX | Immunitybio Inc. | 2.24% | |
| SMMT | Summit Therapeutics Plc Spon Adr | 2.07% | |
| RVMD | Revolution Medicines Inc | 2.02% | |
FAQ
How has CNCR ETF performed?
Quote.FAQ.Answers.ETFs.etf-performance
What is the expense ratio for CNCR?
Quote.FAQ.Answers.ETFs.expense-ratio
What is the Assets Under Management (AUM) for CNCR?
Quote.FAQ.Answers.ETFs.aum
What is the investment style for CNCR?
CNCR follows a Small Cap Blend investment style.
What are the top holdings for CNCR?
The top holdings of CNCR include: JANX (4.17%), MGNX (3.27%), MRSN (3.26%), YMAB (2.85%), FATE (2.74%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for CNCR?
Average daily volume data for CNCR is currently not available.